Abstract
Pharmaceutical and biotechnology industries are experiencing increasing pressures with new drug development timelines. As well as securing a “first to market” commercial advantage, the ability to make rapid decisions during the development cycle of new molecules is crucial.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Notes
- 1.
Reif, O.-W. and Vogt, R. (2006) Innovations in Pharmaceutical Technology, 19, 61–64.
- 2.
Cellexus Technical Note: Low Temperature Accessory – high yields of expressed protein in E.coli.
- 3.
Cellexus Technical Note: Scale-up from a flask to 50 l in a single step using the CellMaker Lite.
- 4.
Osman, et al. (1992) Lonza. Poster: Stirred Tank and Airlift Bioreactors are Interchangeable Systems for Mammalian Cell Culture.
- 5.
Zhang, S., et al. (1992) J. Biotechnol. 25, 289–306.
- 6.
Zhang, S., et al. (1992) J. Biotechnol. 25, 289–306.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this paper
Cite this paper
Auton, K.A. (2010). Single Use Bioreactors: Expressing Protein in Mammalian Cell Suspension. In: Noll, T. (eds) Cells and Culture. ESACT Proceedings, vol 4. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-3419-9_12
Download citation
DOI: https://doi.org/10.1007/978-90-481-3419-9_12
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-3418-2
Online ISBN: 978-90-481-3419-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)